Drug Approval | September 21, 2021
Glenmark receives ANDA approval for treatment of acne
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
PPH is associated with almost 20 per cent of maternal mortality in India
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
Subscribe To Our Newsletter & Stay Updated
